Articles & News

China’s data protection regulations play a crucial role in clinical trials, requiring sponsors and researchers to comply with multiple laws, including the PIPL, GCP-2020, and cross-border data transfer rules. Unlike other jurisdictions, China imposes strict consent requirements, risk assessments, and regulatory filings, making compliance a key factor when selecting trial locations and managing participant data.

ICH-GCP and GDPR are vital for clinical trials, setting standards for participant protection and data integrity, with distinct focuses and enforcement approaches.

Cyber insurance provides coverage to businesses, including those in the life sciences industry, to protect against losses from cyberattacks, such as data breaches, ransomware, and other threats. For life sciences companies, which handle high-value intellectual property and sensitive data, tailored cyber insurance policies offer essential protection against financial, legal, and reputational damage while complementing existing cybersecurity measures.

The UK data watchdog is set to fine NHS vendor Advanced for security failures that occurred before the LockBit ransomware attack. These security lapses contributed to the vulnerability exploited during the attack.

The UK's National Health Service (NHS) has confirmed that data stolen in a ransomware attack on Synnovis, a medical diagnostics service, has been published online, and the extent of the breach and its impact on patients is under investigation.